VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (3)
Four-year follow-up of a single arm, phase II clinical trial of ibrutinib with rituximab (IR) in patients with relapsed/refractory mantle cell lymphoma (MCL).
Frontline therapy
Neutropenias following allogeneic bone marrow transplantation: response to therapy with high-dose intravenous immunoglobulin.
See All 3 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
ANDREEFF, MICHAEL
One or more keywords matched the following items that are connected to
ANDREEFF, MICHAEL
Item Type
Name
Concept
Heterocyclic Compounds, 2-Ring
Concept
Heterocyclic Compounds, 4 or More Rings
Concept
Heterocyclic Compounds, 3-Ring
Academic Article
Preclinical and early clinical evaluation of the oral AKT inhibitor, MK-2206, for the treatment of acute myelogenous leukemia.
Academic Article
Simultaneous inhibition of PDK1/AKT and Fms-like tyrosine kinase 3 signaling by a small-molecule KP372-1 induces mitochondrial dysfunction and apoptosis in acute myelogenous leukemia.
Academic Article
Preclinical activity of the novel B-cell-specific Moloney murine leukemia virus integration site 1 inhibitor PTC-209 in acute myeloid leukemia: Implications for leukemia therapy.
Academic Article
ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies.
Academic Article
Discovery and clinical introduction of first-in-class imipridone ONC201.
Academic Article
The Imipridone ONC201 Induces Apoptosis and Overcomes Chemotherapy Resistance by Up-Regulation of Bim in Multiple Myeloma.
Academic Article
Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.
Search Criteria
Heterocyclic Compounds 4 or More Rings